NCT04404660 2026-04-08
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
Autolus Limited
Phase 1/2 Active not recruiting
Autolus Limited
Regeneron Pharmaceuticals
Hoffmann-La Roche